Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a comprehensive Locations section listing study sites across multiple countries and regions (e.g., United States states such as Alabama, California, Illinois, Louisiana, New York, North Carolina, Pennsylvania, Texas, Washington; Australia, Canada, China, Japan, United Kingdom, and more).SummaryDifference2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe PubMed publications note was updated to clarify that publications are automatically filled from PubMed and may not be about the study, and a new 'Revision: v3.3.2' label was added.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved an administrative funding/update-status disclaimer from the page.SummaryDifference0.2%

- Check59 days agoChange DetectedThe two Taiwan study locations were updated from 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 736' in the Locations section.SummaryDifference0.0%

- Check66 days agoChange DetectedObserved minor UI updates and a recent update timestamp, with no changes to core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check95 days agoChange Detected- Added a government notice about funding and operating status, and a new v3.2.0 revision tag. - Removed the previous v3.1.0 revision tag.SummaryDifference2%

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.